{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-068189","form_type":"8-K","ticker":"ORKA","cik":"0000907654","company_name":"Oruka Therapeutics, Inc.","filed_at":"2023-12-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:32.354501+00:00","generated_at":"2026-06-07T18:28:36.185268+00:00","sec_items":["5.08","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"ARCA biopharma sets Jan 30, 2024 annual meeting, Dec 6 record date, Dec 11 proposal deadline","bullets":["Annual meeting scheduled for January 30, 2024; record date for voting is December 6, 2023.","Shareholder proposals or director nominations must be received by December 11, 2023.","Proxy materials expected to be available beginning on or about December 19, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-068189","json":"https://secwatch.observer/filing/0000950170-23-068189.json","markdown":"https://secwatch.observer/filing/0000950170-23-068189.md","text":"https://secwatch.observer/filing/0000950170-23-068189.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/907654/000095017023068189/0000950170-23-068189-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/907654/000095017023068189/abio-20231204.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T18:28:36.185268+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}